| Ticker: | BLRX |
| Current Price: | $1.30 |
| % Daily Change: | -3.70% |
| Volume (1,000s): | 13.28 |
| Average Volume (1,000s): | 53.84 |
| Market Cap (M): | $6.47 |
| 1/2/2024 Price: | $1.53 |
| Change Since Inception: | -15.03% |
BioLineRx Ltd.
Modi’in Technology Park
2 HaMa’ayan Street
Hevel Modi’in 7177871
Israel
BioLineRx Ltd. is a pre-commercial stage biopharmaceutical company pursuing life-changing therapies for certain cancers and rare diseases. The company is advancing a pipeline of investigational medicines for patients with multiple myeloma, sickle cell disease, pancreatic cancer, and other solid tumors. Headquartered in Israel, and with operations in the U.S., BioLineRx is driving innovative therapeutics with end-to-end expertise in development and commercialization, ensuring life-changing discoveries move beyond the bench to the bedside.